Neurodegeneration in tauopathies and synucleinopathies

Area of Science:

• Neuroscience
• Gerontology
• Immunology

Background:

• Global life expectancy increases, leading to aging societies.
• Aging societies face rising rates of age-related disorders, particularly neurodegenerative diseases.
• Neurodegenerative diseases are characterized by protein aggregation, including tauopathies and alpha-synucleinopathies.

Purpose of the Study:

• To highlight the multifactorial etiology of neurodegenerative diseases.
• To emphasize the need for deeper understanding of genetic and immunological factors.
• To underscore the importance of this knowledge for developing novel diagnostic and therapeutic strategies.

Main Methods:

• Review of current literature on neurodegenerative disease characteristics.
• Analysis of known risk factors, including genetic, environmental, and lifestyle elements.
• Examination of protein aggregation mechanisms central to disease pathology.

Main Results:

• Neurodegenerative diseases are a significant medical challenge in aging populations.
• Key disease groups include tauopathies, alpha-synucleinopathies, and glutamine repeat disorders.
• Protein aggregation is a common molecular signature across various neurodegenerative conditions.
• Multifactorial etiology involves genetics, age, immune/metabolic conditions, and environmental factors.

Conclusions:

• Further research into genetic and adaptive immunological characteristics is crucial.
• This knowledge is essential for developing innovative diagnostic and therapeutic approaches.
• The ultimate goal is to delay or reverse the progression of neurodegenerative diseases.